An abnormal surge in RSV was observed in the spring and fall 2022 seasons, but new immunizations offer protections previously unavailable.
Lori Handy, MD, MSCE
Advertisement
Articles by Lori Handy, MD, MSCE
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
FDA approves elinzanetant (Lynkuet) for vasomotor menopausal symptoms
2
Estrogen therapy shows mixed mental health effects in menopause
3
Earlier menopause, reduced cardiac function jointly linked to poorer brain health in women
4
Elinzanetant demonstrates favorable safety profile in menopausal women, with James A. Simon, MD
5
